Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.

European journal of cancer (Oxford, England : 1990)（2023）

引用 4|浏览64

暂无评分

摘要

Baseline sPD-L1 levels have the potential to predict survival for advanced GC patients treated with nivolumab, with the prognostic accuracy of sPD-L1 being improved by its combination with GPS.

查看译文

关键词

Gastric cancer,Nivolumab,Soluble CTLA-4,Soluble PD-1,Soluble PD-L1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要